EUVIMEDEUVIMED entdecken
Open Access

Effectiveness of Using Patient-Defined Meal Sizes to Determine Bolus Doses of Insulin

Mayer B Davidson iD, Ligaya D Scarlett, Petra Duran, Karen W Jenne, Phoebe Shinn, Emily Woodcock

Diabetes Obesity and Cardiometabolic CARE · 2026

DOI: 10.2337/doc25-0018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Obesity and Cardiometabolic CARE, 2026. Verfasst von Mayer B Davidson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Charles R. Drew University, Los Angeles, CA. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE Some individuals with diabetes requiring bolus insulin doses do not have access to dietitians to teach advanced carbohydrate counting. In this situation, meal sizes defined by individuals taking bolus insulin have been used to determine doses. This observational study evaluated the effectiveness of this approach. RESEARCH DESIGN AND METHODS In a diabetes program serving a minority population with low socioeconomic status (SES), primary care nurse practitioners (NPs) trained in diabetes care spent one-third of their time managing referred participants with diabetes who had A1C levels ≥9.0% for ≥6 months. They interacted with participants taking bolus insulin (telephonically or in person) every 3–4 weeks until there were no dose adjustments made based on glucose patterns and then every 6 weeks. NPs followed these participants for up to 1 year before referring them back to their primary care clinicians, either when they achieved target A1C levels (measured every 3 months) of ≤7.5% or at 1 year. The primary outcome of changes in baseline A1C levels evaluates the effectiveness of NPs using patient-defined meal sizes. RESULTS NPs managed 149 participants requiring bolus doses. Baseline A1C levels had significantly decreased (P < 0.001) by 3.2%, from 10.3% to 7.1%, at the time of referral of participants back to their primary care clinicians. Ninety-five percent of participants achieved target A1C levels of ≤7.5% after a mean of 6.1 months. CONCLUSIONS Experienced clinicians using patient-defined meal sizes to determine bolus insulin doses who frequently interact with patients can optimize glycemia in those with high A1C levels from minority populations with low SES.

Autor:innen und Institutionen

  • Charles R. Drew University, Los Angeles, CA.
  • Venice Family Clinic, Venice, CA.

ORCID-Profile: Mayer B Davidson

Zitieren

APA

Davidson, M. B., Scarlett, L. D., Duran, P., Jenne, K. W., Shinn, P., & Woodcock, E. (2026). Effectiveness of Using Patient-Defined Meal Sizes to Determine Bolus Doses of Insulin. Diabetes Obesity and Cardiometabolic CARE. https://doi.org/10.2337/doc25-0018

Vancouver

Davidson MB, Scarlett LD, Duran P, Jenne KW, Shinn P, Woodcock E. Effectiveness of Using Patient-Defined Meal Sizes to Determine Bolus Doses of Insulin. Diabetes Obesity and Cardiometabolic CARE. 2026. doi:10.2337/doc25-0018

BibTeX
@article{Davidson2026,
  author = {Davidson, Mayer B and Scarlett, Ligaya D and Duran, Petra and Jenne, Karen W and Shinn, Phoebe and Woodcock, Emily},
  title = {Effectiveness of Using Patient-Defined Meal Sizes to Determine Bolus Doses of Insulin},
  journal = {Diabetes Obesity and Cardiometabolic CARE},
  year = {2026},
  doi = {10.2337/doc25-0018}
}
Kostenlos starten →